Why KTEK Aerosystems (ASX:KTK) is leaning on a US export licence and a drone contract to restart sales

Sonal Goyal

04 November 2026 10:15 PM AEDT

Why KTEK Aerosystems (ASX:KTK) is leaning on a US export licence and a drone contract to restart sales

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

• KTEK is trying to restart deliveries that stalled in the first half of 2026.

• A US export licence has been granted for its Netherlands subsidiary.

• A drone contract is also part of the restart plan.

• Both steps were announced in August and September 2026.

KTEK Aerosystems (ASX:KTK) is trying to restart deliveries that stalled in the first half of 2026, and two August and September announcements show how. A US export licence for its Netherlands Subsidiary and a fixed-price drone prototype contract with Vestal Technology both point to Revenue resuming, though neither is large next to the half-year loss.

What KTEK makes

KTEK Aerosystems (ASX:KTK) Ltd designs, engineers and manufactures advanced composite structures and assemblies for aerospace and defence customers. Its revenue has come mainly from a small number of customers in Israel's aerospace and defence industry, with further sales to customers in Europe. It reports in US dollars.

The company reached the ASX through a reverse Acquisition of KTeK Ltd, completed on 12 May 2026. A public offer raised A$10 million before costs from 50 million shares at A$0.20, and the shares began trading on 18 May 2026 under the code KTK. The ASX classifies the company in the industrials sector, within capital goods.

A half-year when deliveries stopped

In the half-year to 30 June 2026, revenue fell 82.2 per cent to US$282,845 from US$1,590,541 a year earlier. The loss after tax was US$3,130,384, against US$423,293.

Two items inflate that loss: a US$1,124,135 reverse-acquisition expense and US$540,585 of share-based payments. Excluding both, the loss was US$1,465,664.

The company attributed the revenue fall to suspended deliveries, caused by logistics constraints, delayed export licences and the qualification of new production tooling. Cash was US$3,232,073 at 30 June 2026, up from US$56,689 at 31 December 2025, after the public offer. Net Assets were US$4,319,150.

Two steps towards restarting revenue

On 12 August 2026 KTEK announced that the Netherlands Central Import and Export Office had approved an export licence for its Netherlands facility. Components made in its European operations can now be exported to the United States, assembled there and delivered under a specified US customer programme. The customers are not named, and the release does not state how long the licence lasts.

On 9 September 2026 KTEK announced a binding fixed-price contract worth US$172,500 with Vestal Technology, an Israel-based developer of electric unmanned aircraft built around its patented SCOOP wing technology. The SCOOPER 25 has a maximum take-off mass of up to 25 kilograms and targets defence, surveillance and mapping uses. KTEK will take Vestal's SCOOPER 25 structural design to prototype readiness, make tooling, complete static structural analysis and build two composite prototype airframes.

The first prototype is targeted within five months of project start and the second about a month later. The contract does not guarantee follow-on orders, and further Manufacturing would need a separate commercial agreement.

What the evidence means and the risks

The first-half numbers describe a Business paused by regulatory and production bottlenecks rather than one that has lost its customers, but that distinction only holds if deliveries resume. The company targeted September 2026, and said deliveries of about US$100,000 were made in August.

Its going-concern assessment covers the 15 months to 31 October 2027 and depends on resuming deliveries, collecting receivables, including from its controlling shareholder, and continued access to Israeli bank facilities. Those include a US$369,128 Loan repayable in June 2027, secured by a US$500,429 pledged deposit, and a US$805,369 term loan repayable through June 2032.

Customer concentration, export-control approvals and operating from Israel and the Netherlands are further risks. Net cash used in Operating Activities was US$1,750,588 in the half-year, so the cash balance covers roughly eleven months at that rate, before any collections or new funding.

What to watch

Investors will look for evidence that deliveries have resumed at a meaningful scale, progress on extending the licence to Israel, the first Vestal prototype and the next periodic report. The company's financial year ends on 31 December, and no results date has been announced.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.